<DOC>
	<DOC>NCT02187484</DOC>
	<brief_summary>The antihypertensive effect, safety and usefulness of treatment with BIBR 277 capsules were evaluated in hypertensive patients with nephropathy</brief_summary>
	<brief_title>BIBR 277 Capsules in Hypertensive Patients With Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Condition: Either of the following criteria is satisfied in laboratory tests: Presence of a renal parenchymal disorder such as chronic glomerulonephritis is confirmed (serum creatinine &lt; 3.0 mg/dL) Presence of a renal function disorder (serum creatinine ≥ 1.5 mg/dL to &lt; 3.0 mg/dL) Age: ≥ 20 years Sex: Either male or female Patient status: Either outpatients or inpatients. However, the patient status should remain unchanged throughout the study period Blood pressure (BP): [Outpatients] The last 2 measurements of sitting BP out of at least 3 taken during the observation period (2 4 weeks) should be stable and a mean of the two measurements should be ≥160 mmHg for systolic BP (SBP) and ≥95 mmHg for diastolic BP (DBP) [Inpatients] The last 2 measurements of supine BP taken during the observation period (1 week) should be stable and a mean of the 2 measurements should be ≥ 150 mmHg for SBP and ≥ 90 mmHg for DBP Renovascular hypertension Undergoing haemodialysis Severe hypertension (Diastolic BP ≥ 120 mmHg) Severe heart failure, angina pectoris, or history of myocardial infarction Atrioventricular conduction disturbance (degree II to III), atrial fibrillation, or serious arrhythmia Symptoms of cerebrovascular disorder Serious hepatic dysfunction Uncontrolled diabetes Peptic ulcer History of hypersensitivity to drugs Hyperkalaemia Undergoing treatment with a digitalis preparation Pregnant, breast feeding, possibly pregnant or planning to become pregnant during this study Otherwise judged ineligible by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>